It is a pharma private limited company based in Pimpri, Maharashtra, India, established in 2016.
2016 | Pimpri, Maharashtra, India | ActiveHumanize Pharmaceuticals Private Limited, a active private limited company, was established on 11 March 2016 in Pimpri, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999PN2016PTC158796. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.90 M.
It upholds a compliant status. Its leadership includes Prithviraj Bhupal Desai (Director), Vishwanath Kadappa Hanji (Director), Ajit Ramrao Desai (Director). Past directors included Ijaj Abdulgani Khalif, Ravindra Dundappa Hattarki, Swati Gajendra Bandi. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Fl. B-07, Sect. 07, Plot 80/5, Arihant Properties, Bhosari,, Pimpri, Maharashtra, 411019.
U74999PN2016PTC158796
158796
11 March 2016
₹1.00 M
₹0.90 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Humanize Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prithviraj Bhupal Desai | Director | 11 Mar 2016 | Current |
| Vishwanath Kadappa Hanji | Director | 11 Mar 2016 | Current |
| Ajit Ramrao Desai | Director | 11 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Feb 2025 | Past |
| Pramod Abcsdd | Director | 05 Sep 2016 | Past |
| Pramod Abcsdd | Director | 24 Feb 2025 | Past |
| Pramod Abcsdd | Director | 24 Feb 2025 | Past |
| Pramod Abcsdd | Director | 12 Oct 2017 | Past |
| Pramod Abcsdd | Director | 05 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Humanize Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 3.71% increase. The company also saw a substantial improvement in profitability, with a 71.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Humanize Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2025 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Humanize Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Humanize Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Humanize Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 10.00 M with Charge ID 101116376 was registered on 21 Mar 2025. was recorded as a recent event.
Progress on Humanize Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Humanize Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
Progress on Prithviraj Bhupal Desai was appointed as a Director was appointed as a Director on 11 Mar 2016 & has been associated with this company since 9 years 8 months . was documented.
Vishwanath Kadappa Hanji was appointed as a Director was appointed as a Director on 11 Mar 2016 & has been associated with this company since 9 years 8 months . was recorded as a recent event.
Progress on Ajit Ramrao Desai was appointed as a Director was appointed as a Director on 11 Mar 2016 & has been associated with this company since 9 years 8 months . was documented.
The CIN of Humanize Pharmaceuticals Private Limited is U74999PN2016PTC158796.
Humanize Pharmaceuticals Private Limited is headquartered at Fl. B-07, Sect. 07, Plot 80/5, Arihant Properties, Bhosari,, Pimpri, Maharashtra, 411019.
Humanize Pharmaceuticals Private Limited was incorporated on 11 March 2016.
The current directors of Humanize Pharmaceuticals Private Limited are
The primary industry of Humanize Pharmaceuticals Private Limited is Trade.
Humanize Pharmaceuticals Private Limited is unlisted.
The authorized capital of Humanize Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.90 M.
The compliance status of Humanize Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX